Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Probiotic484 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A13315 | 30036479 | Mol Pharm | Diammonium Glycyrrhizinate Protects against Nonalcoholic Fatty Liver Disease in Mice through Modulation of Gut Microbiota and Restoration of Intestinal Barrier. | 2018 | Details |
| A13524 | 29931231 | J Nutr | Daily Consumption of Synbiotic Yogurt Decreases Liver Steatosis in Patients with Nonalcoholic Fatty Liver Disease: A Randomized Controlled Clinical Trial. | 2018 | Details |
| A13526 | 29930468 | World J Gastroenterol | Dynamic alterations in the gut microbiota and metabolome during the development of methionine-choline-deficient diet-induced nonalcoholic steatohepatitis. | 2018 | Details |
| A13614 | 29874807 | Med Sci (Basel) | The Role of the Gut Microbiome in Nonalcoholic Fatty Liver Disease. | 2018 | Details |
| A13648 | 29857146 | Clin Gastroenterol Hepatol | Evaluations of Lifestyle, Dietary, and Pharmacologic Treatments for Pediatric Nonalcoholic Fatty Liver Disease: A Systematic Review. | 2018 | Details |
| A13702 | 29800811 | J Nutr Biochem | Synbiotics Bifidobacterium infantis and milk oligosaccharides are effective in reversing cancer-prone nonalcoholic steatohepatitis using western diet-fed FXR knockout mouse models. | 2018 | Details |
| A13728 | 29787859 | Contemp Clin Trials | Design and rationale of the INSYTE study: A randomised, placebo controlled study to test the efficacy of a synbiotic on liver fat, disease biomarkers and intestinal microbiota in non-alcoholic fatty liver disease. | 2018 | Details |
| A13769 | 29765460 | Arch Med Sci | The role of intestinal microbiota in the pathogenesis of NAFLD: starting points for intervention. | 2016 | Details |
| A13822 | 29740791 | Paediatr Drugs | Nonalcoholic Fatty Liver Disease in Children: Not a Small Matter. | 2018 | Details |
| A13884 | 29710519 | Biomed Pharmacother | Effects of shenling baizhu powder herbal formula on intestinal microbiota in high-fat diet-induced NAFLD rats. | 2018 | Details |
| A13948 | 29675053 | Evid Based Complement Alternat Med | The Potential Effect of Chinese Herbal Formula Hongqijiangzhi Fang in Improving NAFLD: Focusing on NLRP3 Inflammasome and Gut Microbiota. | 2018 | Details |
| A13994 | 29653359 | J Nutr Biochem | The role of the gut microbiota in the pathology and prevention of liver disease. | 2018 | Details |
| A14016 | 29633106 | Inflammopharmacology | Probiotic mixture of Lactobacillus and Bifidobacterium alleviates systemic adiposity and inflammation in non-alcoholic fatty liver disease rats through Gpr109a and the commensal metabolite butyrate. | 2018 | Details |
| A14162 | 29557414 | J Gastrointestin Liver Dis | A Multi-strain Probiotic Reduces the Fatty Liver Index, Cytokines and Aminotransferase levels in NAFLD Patients: Evidence from a Randomized Clinical Trial. | 2018 | Details |
| A14372 | 29441049 | Front Microbiol | Intestinal Microbiome Shifts, Dysbiosis, Inflammation, and Non-alcoholic Fatty Liver Disease. | 2018 | Details |
| A14424 | 29413959 | Redox Biol | Role of gut microbiota and oxidative stress in the progression of non-alcoholic fatty liver disease to hepatocarcinoma: Current and innovative therapeutic approaches. | 2018 | Details |
| A14473 | 29397594 | Zhonghua Nei Ke Za Zhi | [Efficacy of probiotics on the treatment of non-alcoholic fatty liver disease]. | 2018 | Details |
| A14502 | 29379536 | Arch Med Sci | Bifidobacteria and lactobacilli in the gut microbiome of children with non-alcoholic fatty liver disease: which strains act as health players? | 2016 | Details |
| A14554 | 29356764 | J Pediatr Gastroenterol Nutr | Pediatric Nonalcoholic Fatty Liver Disease: Current Thinking. | 2018 | Details |
| A14561 | 29353414 | Probiotics Antimicrob Proteins | Oral Administration of Compound Probiotics Ameliorates HFD-Induced Gut Microbe Dysbiosis and Chronic Metabolic Inflammation via the G Protein-Coupled Receptor 43 in Non-alcoholic Fatty Liver Disease Rats. | 2019 | Details |
| A14609 | 29325294 | Zhonghua Gan Zang Bing Za Zhi | [Effects of Lactobacillus paracasei N1115 combined with fructooligosaccharides on non-alcoholic fatty liver disease induced by high-fat diet in mice]. | 2017 | Details |
| A14629 | 29316191 | Liver Transpl | Microbiota and the liver. | 2018 | Details |
| A14644 | 29311399 | Ann Hepatol | Efficacy of Probiotics and Smectite in Rats with Non-Alcoholic Fatty Liver Disease. | 2018 | Details |
| A14665 | 29298969 | Pol Merkur Lekarski | [Dietetary recommendation for non-alcoholic fatty liver disease]. | 2017 | Details |
| A14816 | 29222051 | Biochem Biophys Res Commun | Long-term fermented soybean paste improves metabolic parameters associated with non-alcoholic fatty liver disease and insulin resistance in high-fat diet-induced obese mice. | 2017 | Details |
| A14850 | 29204050 | World J Gastroenterol | Current and emerging pharmacological therapy for non-alcoholic fatty liver disease. | 2017 | Details |
| A14859 | 29201794 | Euroasian J Hepatogastroenterol | Role of Probiotics in the Treatment of Nonalcoholic Fatty Liver Disease: A Meta-analysis. | 2017 | Details |
| A14860 | 29201787 | Euroasian J Hepatogastroenterol | Probiotic Therapy in Patients with Nonalcoholic Steatohepatitis in Zagazig University Hospitals. | 2017 | Details |
| A14977 | 29148175 | J Dig Dis | Treatment efficacy of a probiotic preparation for non-alcoholic steatohepatitis: A pilot trial. | 2017 | Details |
| A15080 | 29106426 | Food Funct | Effect of a novel potential probiotic Lactobacillus paracasei Jlus66 isolated from fermented milk on nonalcoholic fatty liver in rats. | 2017 | Details |
| A15082 | 29106066 | J Dig Dis | Pharmacotherapy of nonalcoholic steatohepatitis: Reflections on the existing evidence. | 2017 | Details |
| A15110 | 29089934 | Front Microbiol | Prebiotic and Synbiotic Modifications of Beta Oxidation and Lipogenic Gene Expression after Experimental Hypercholesterolemia in Rat Liver. | 2017 | Details |
| A15130 | 29083037 | Aliment Pharmacol Ther | Review article: the gut microbiome as a therapeutic target in the pathogenesis and treatment of chronic liver disease. | 2017 | Details |
| A15228 | 29035308 | Nutrients | Gut Microbiota and Nonalcoholic Fatty Liver Disease: Insights on Mechanisms and Therapy. | 2017 | Details |
| A15259 | 29019564 | Arq Bras Cir Dig | THE IMPACT OF THE USE OF SYMBIOTICS IN THE PROGRESSION OF NONALCOHOLIC FATTY LIVER DISEASE IN A RAT MODEL. | 2018 | Details |
| A15273 | 28990516 | Curr Med Chem | Gut Microbiota as a Therapeutic Target for Metabolic Disorders. | 2018 | Details |
| A15291 | 28983453 | Curr Pharmacol Rep | Remote Sensing between Liver and Intestine: Importance of Microbial Metabolites. | 2017 | Details |
| A15305 | 28972878 | Discov Med | Role of nutrition, gene polymorphism, and gut microbiota in non-alcoholic fatty liver disease. | 2017 | Details |
| A15313 | 28970836 | Front Immunol | Fructose: A Dietary Sugar in Crosstalk with Microbiota Contributing to the Development and Progression of Non-Alcoholic Liver Disease. | 2017 | Details |
| A15390 | 28933748 | Nutrients | Dietary Composition Independent of Weight Loss in the Management of Non-Alcoholic Fatty Liver Disease. | 2017 | Details |
| A15405 | 28927250 | Minerva Gastroenterol Dietol | Gut microbiota and the liver. | 2017 | Details |
| A15465 | 28894517 | Middle East J Dig Dis | Effects of Probiotic and Prebiotic Supplementation on Leptin, Adiponectin, and Glycemic Parameters in Non-alcoholic Fatty Liver Disease: A Randomized Clinical Trial. | 2017 | Details |
| A15542 | 28852205 | Int J Obes (Lond) | Probiotics administration following sleeve gastrectomy surgery: a randomized double-blind trial. | 2017 | Details |
| A15566 | 28840806 | Microbiol Spectr | Microbiota, Liver Diseases, and Alcohol. | 2017 | Details |
| A15681 | 28767077 | Children (Basel) | Gut-Liver Axis Derangement in Non-Alcoholic Fatty Liver Disease. | 2017 | Details |
| A15736 | 28737568 | J Pediatr Gastroenterol Nutr | Systematic Review: Nutrition and Physical Activity in the Management of Paediatric Nonalcoholic Fatty Liver Disease. | 2017 | Details |
| A15796 | 28705785 | Turk J Gastroenterol | Determination of certain bacterial groups in gut microbiota and endotoxin levels in patients with nonalcoholic steatohepatitis. | 2017 | Details |
| A15829 | 28691342 | Mol Nutr Food Res | Dual function of Lactobacillus kefiri DH5 in preventing high-fat-diet-induced obesity: direct reduction of cholesterol and upregulation of PPAR-α in adipose tissue. | 2017 | Details |
| A15947 | 28640662 | Gut Microbes | Using probiotics in clinical practice: Where are we now? A review of existing meta-analyses. | 2017 | Details |
| A15995 | 28621554 | Expert Rev Gastroenterol Hepatol | Gut microbiota changes and chronic hepatitis C virus infection. | 2017 | Details |
| A16011 | 28612527 | Sichuan Da Xue Xue Bao Yi Xue Ban | [The Effect of p-JAK1/p-STAT3 Signaling Way in Intervening NAFLD by Blueberry Probiotic Serum]. | 2017 | Details |
| A16125 | 28550391 | Hepatol Int | Gut-liver axis, cirrhosis and portal hypertension: the chicken and the egg. | 2017 | Details |
| A16174 | 28521872 | Metabolism | Non-alcoholic fatty liver disease: An update with special focus on the role of gut microbiota. | 2017 | Details |
| A16225 | 28501229 | Prim Care | Integrative Medicine for Gastrointestinal Disease. | 2017 | Details |
| A16370 | 28432400 | Internist (Berl) | [The intestinal microbiome and metabolic diseases : From obesity to diabetes and nonalcoholic steatohepatitis]. | 2017 | Details |
| A16381 | 28426878 | Carcinogenesis | Microbiota, NASH, HCC and the potential role of probiotics. | 2017 | Details |
| A16443 | 28384519 | J Nutr Biochem | Kefir alleviates obesity and hepatic steatosis in high-fat diet-fed mice by modulation of gut microbiota and mycobiota: targeted and untargeted community analysis with correlation of biomarkers. | 2017 | Details |
| A16455 | 28376573 | Aust Fam Physician | The gut microbiome. | 2017 | Details |
| A16502 | 28349964 | Sci Rep | Probiotics may delay the progression of nonalcoholic fatty liver disease by restoring the gut microbiota structure and improving intestinal endotoxemia. | 2017 | Details |
| A16517 | 28345499 | Br J Nutr | Synbiotic supplementation in lean patients with non-alcoholic fatty liver disease: a pilot, randomised, double-blind, placebo-controlled, clinical trial. | 2017 | Details |
| A16578 | 28298269 | Adv Nutr | Nonalcoholic Fatty Liver Disease, the Gut Microbiome, and Diet. | 2017 | Details |
| A16587 | 28297790 | Zhonghua Gan Zang Bing Za Zhi | [Role of probiotics in treatment of nonalcoholic fatty liver disease]. | 2017 | Details |
| A16652 | 28264426 | Nutrients | The Combination of Blueberry Juice and Probiotics Ameliorate Non-Alcoholic Steatohepatitis (NASH) by Affecting SREBP-1c/PNPLA-3 Pathway via PPAR-α. | 2017 | Details |
| A16710 | 28230607 | J Pediatr Gastroenterol Nutr | Effects of Probiotics on Nonalcoholic Fatty Liver Disease in Obese Children and Adolescents. | 2017 | Details |
| A16829 | 28143996 | Acta Med Indones | The Role of Probiotic in Reducing Hepatic Inflammation Among NAFLD Patients: an Evidence-based Case Report. | 2016 | Details |
| A16933 | 28086768 | BMC Complement Altern Med | Probiotic mixture improves fatty liver disease by virtue of its action on lipid profiles, leptin, and inflammatory biomarkers. | 2017 | Details |
| A16962 | 28073414 | Zhonghua Gan Zang Bing Za Zhi | [Protective effect of Saccharomyces boulardii against intestinal mucosal barrier injury in rats with nonalcoholic fatty liver disease]. | 2016 | Details |
| A17439 | 27787945 | J Diabetes | Personalized microbiome-based approaches to metabolic syndrome management and prevention. | 2017 | Details |
| A17570 | 27741171 | J Clin Gastroenterol | Gut Microbiota and the Liver: A Tale of 2 Cities: A Narrative View in 2 Acts. | 2017 | Details |
| A17653 | 27686615 | Am J Physiol Gastrointest Liver Physiol | Precision medicine in alcoholic and nonalcoholic fatty liver disease via modulating the gut microbiota. | 2016 | Details |
| A17682 | 27660157 | Probiotics Antimicrob Proteins | Probiotics Supplemented with Omega-3 Fatty Acids are More Effective for Hepatic Steatosis Reduction in an Animal Model of Obesity. | 2017 | Details |
| A17929 | 27470892 | Zhonghua Gan Zang Bing Za Zhi | [Influence of gut microecology on the pathogenesis and treatment of nonalcoholic fatty liver disease]. | 2016 | Details |
| A18020 | 27409822 | Endocr Pract | GUT MICROBIOTA, PREBIOTICS, PROBIOTICS, AND SYNBIOTICS IN MANAGEMENT OF OBESITY AND PREDIABETES: REVIEW OF RANDOMIZED CONTROLLED TRIALS. | 2016 | Details |
| A18056 | 27380600 | J Pediatr Gastroenterol Nutr | Pediatric NAFLD: the Future role of Patient-Tailored Probiotics Therapy. | 2016 | Details |
| A18073 | 27367724 | Nutrients | Beneficial Effect of Synbiotic Supplementation on Hepatic Steatosis and Anthropometric Parameters, But Not on Gut Permeability in a Population with Nonalcoholic Steatohepatitis. | 2016 | Details |
| A18185 | 27304953 | Int J Mol Sci | Effects of Probiotics and Synbiotics on Obesity, Insulin Resistance Syndrome, Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease: A Review of Human Clinical Trials. | 2016 | Details |
| A18227 | 27273168 | Nat Rev Gastroenterol Hepatol | The role of the gut microbiota in NAFLD. | 2016 | Details |
| A18473 | 27105827 | Nutr J | Pathophysiological role of host microbiota in the development of obesity. | 2016 | Details |
| A18516 | 27076897 | Int J Prev Med | The Effect of Symbiotic Supplementation on Liver Enzymes, C-reactive Protein and Ultrasound Findings in Patients with Non-alcoholic Fatty Liver Disease: A Clinical Trial. | 2016 | Details |
| A18539 | 27063274 | Clin Liver Dis | Current Pharmacologic Therapy for Nonalcoholic Fatty Liver Disease. | 2016 | Details |
| A18545 | 27063268 | Clin Liver Dis | Nonalcoholic Fatty Liver Disease and the Gut Microbiome. | 2015 | Details |
| A18573 | 27052013 | Dig Dis Sci | Lifestyle and Dietary Interventions in the Management of Nonalcoholic Fatty Liver Disease. | 2016 | Details |
| A18581 | 27048904 | Best Pract Res Clin Gastroenterol | Intestinal microbiota in liver disease. | 2016 | Details |
| A18591 | 27043550 | Int J Mol Sci | Diet, Microbiota, Obesity, and NAFLD: A Dangerous Quartet. | 2016 | Details |
| A18596 | 27041377 | Dig Dis Sci | Lifestyle Interventions Including Nutrition, Exercise, and Supplements for Nonalcoholic Fatty Liver Disease in Children. | 2016 | Details |
| A18632 | 27023533 | Int J Mol Sci | Gut Microbiota and Lifestyle Interventions in NAFLD. | 2016 | Details |
| A18633 | 28868449 | GE Port J Gastroenterol | Microbiota Modulation With Synbiotic Decreases Liver Fibrosis in a High Fat Choline Deficient Diet Mice Model of Non-Alcoholic Steatohepatitis (NASH). | 2016 | Details |
| A18642 | 27018382 | Biochem Biophys Res Commun | Protective effects of Lactobacillus rhamnosus GG against dyslipidemia in high-fat diet-induced obese mice. | 2016 | Details |
| A18661 | 27006654 | Gastroenterol Res Pract | A Comprehensive Updated Review of Pharmaceutical and Nonpharmaceutical Treatment for NAFLD. | 2016 | Details |
| A18742 | 26976285 | BMC Gastroenterol | Comparative experimental investigation on the efficacy of mono- and multiprobiotic strains in non-alcoholic fatty liver disease prevention. | 2016 | Details |
| A18928 | 26866817 | Hepatol Res | Efficacy of probiotics in non-alcoholic fatty liver disease in adult and children: A meta-analysis of randomized controlled trials. | 2016 | Details |
| A19275 | 26663004 | Hepatobiliary Pancreat Dis Int | Gut microbiota and non-alcoholic fatty liver disease. | 2015 | Details |
| A19279 | 26657927 | Minerva Gastroenterol Dietol | Probiotics in digestive diseases: focus on Lactobacillus GG. | 2015 | Details |
| A19376 | 26600078 | Hepatology | The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota. | 2016 | Details |
| A19460 | 26556989 | World J Gastroenterol | Gut microbiota and host metabolism in liver cirrhosis. | 2015 | Details |
| A19508 | 26516851 | Int J Mol Sci | Heat Killed Lactobacillus reuteri GMNL-263 Reduces Fibrosis Effects on the Liver and Heart in High Fat Diet-Hamsters via TGF-β Suppression. | 2015 | Details |
| A19521 | 26512643 | Int J Mol Sci | Relevant Aspects of Nutritional and Dietary Interventions in Non-Alcoholic Fatty Liver Disease. | 2015 | Details |
| A19622 | 26450277 | Br J Nutr | Supplementation of sodium butyrate protects mice from the development of non-alcoholic steatohepatitis (NASH). | 2015 | Details |
| A19623 | 26449892 | Nutr Clin Pract | Role of the Gut Microbiome in Nonalcoholic Fatty Liver Disease. | 2015 | Details |
| A19629 | 26447961 | J Clin Gastroenterol | Probiotics in Nonalcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis, and Cirrhosis. | 2016 | Details |